HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

DOCS

Doximity, Inc. (Russell 2000)

Healthcare — Health Information Services

Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company also offers workflow tools, including Ask, a HIPAA-compliant AI assistant, to access and apply evidence-based medical information within clinical workflows; Scribe, a HIPAA-compliant, AI-powered clinical documentation tool; Telehealth tools for hospitals and health systems; and AMiON, an on-call scheduling tool. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Hold 2.6 / 5 18 analysts
$28.50
+$0.16 (+0.56%)
Target: $29.67 (4.1%)

Price History

52-Week Range
Sign in to add DOCS to a watchlist or set price alerts.

Fundamentals

Market Cap$5.08B
P/E Ratio (TTM)33.53
Forward P/E18.30
EPS (TTM)$0.85
Dividend Yield-
Profit Margin25.48%
Revenue Growth7.30%
ROE17.21%
Debt/Equity1.06
Recommendation Hold 2.6
Analyst Target$29.67
Analysts18
Next Earnings Aug 6, 2026 AMC
Indexes Russell 2000

Technical Indicators

RSI (14)70.8
Beta1.25
SMA 20$26.25
SMA 40$25.85
52-Week High$74.33
52-Week Low$17.15
50-Day Avg$24.77
200-Day Avg$26.95
Avg Volume$4.45M
Volume$3.34M

Performance Analysis

BULLISH

DOCS shows predominantly bullish signals based on its fundamentals and technicals.

~ Trading at 20% of its 52-week range.
- RSI at 70.8 indicates overbought conditions — a pullback may be due.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
~ Modest revenue growth of 7.3% year-over-year.
+ Healthy profit margin of 25.5%.
~ Wall Street consensus is "Hold" from 18 analysts.
+ Average analyst target of $29.67 implies 4.1% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Oct 01, 2026 21:01 UTC

Back to Screener Export Report